BRAVOZAN

Serial Number 87010617
606

Registration Progress

Application Filed
Apr 22, 2016
Under Examination
Oct 4, 2016
Approved for Publication
Aug 9, 2016
Published for Opposition
Aug 9, 2016
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: BRAVOZAN
Previous Owner: Glaxo Group Limited
Classes: 005

Trademark Image

BRAVOZAN

Basic Information

Serial Number
87010617
Filing Date
April 22, 2016
Published for Opposition
August 9, 2016
Abandonment Date
November 5, 2018
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 5, 2018
Classes
005

Rights Holder

Glaxo Group Limited

99
Address
980 Great West Road
Brentford, Middlesex TW89GS

Ownership History

Glaxo Group Limited

Original Applicant
99
Brentford, Middlesex

Glaxo Group Limited

Owner at Publication
99
Brentford, Middlesex

Legal Representation

Attorney
Angela L. Wilson

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

28 events
Date Code Type Description Documents
Nov 5, 2018 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Nov 5, 2018 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 26, 2018 PCDE O PETITION TO DIRECTOR DENIED Loading...
May 16, 2018 PILM I PETITION INQUIRY LETTER ISSUED Loading...
May 14, 2018 APET A ASSIGNED TO PETITION STAFF Loading...
Apr 6, 2018 44EP I 44(e) PETITION - RECEIVED Loading...
Apr 30, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 6, 2018 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
Mar 31, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 29, 2018 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 29, 2018 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 29, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 23, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 21, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 21, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 21, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 7, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 4, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 4, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 4, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 4, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 9, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 9, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 20, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 6, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 5, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 27, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 26, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Translation
The wording "BRAVOZAN" has no meaning in a foreign language.

Classification

International Classes
005